Secondary Logo

Journal Logo

Articles by Kathleen Lomax, M.D.

Achievement of Early Deep Remission Predicts Better Long-Term Outcomes for Adalimumab-Treated Patients with Crohn's Disease: Data from EXTEND: 1190

Colombel, Jean-Frédéric; Rutgeerts, Paul; Sandborn, William; More

American Journal of Gastroenterology. 105:S434-S435, October 2010.

Achievement of Early Deep Remission Is Associated with Lower Rates of Weekly Dosing for Adalimumab-Treated Patients with Crohn's Disease: Data from EXTEND: 1208

Sandborn, William; Colombel, Jean-Frédéric; Lomax, Kathleen; More

American Journal of Gastroenterology. 105:S442-S443, October 2010.